The following statement is attributable to:
Susan R. Bailey, M.D.
President, American Medical Association
“For much of this year, physicians, nurses and frontline health care personnel have done herculean, unprecedented work to care for patients and prevent the spread of COVID-19 – all while scientists and researchers sprinted to develop a safe and effective vaccine. After a thorough, rigorous, transparent review process, today’s decision by the FDA to grant an Emergency Use Authorization (EUA) for the first COVID-19 vaccine developed by Pfizer and BioNTech is a monumental milestone with the potential to set us on a road to recovery. The comprehensive, science-based, transparent nature of this process is critical to inspiring the public’s confidence in this vaccine.
“We now look forward to the Advisory Committee on Immunization Practices’ (ACIP) open deliberations and their recommendations to the CDC Director for use of the vaccine in the US population to control COVID-19.”
ph: (312) 464-4443
About the American Medical Association
The American Medical Association is the physicians’ powerful ally in patient care. As the only medical association that convenes 190+ state and specialty medical societies and other critical stakeholders, the AMA represents physicians with a unified voice to all key players in health care. The AMA leverages its strength by removing the obstacles that interfere with patient care, leading the charge to prevent chronic disease and confront public health crises and, driving the future of medicine to tackle the biggest challenges in health care.